According to Latest study , the global market for Cancer Gene Testing Service should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By country, China accounted for percent of the global market last year and China’s market share increased from percent to percent. China Cancer Gene Testing Service market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029. The United States Cancer Gene Testing Service market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By segment, Hospital grew percent to account for percent of the total market sales, and Clinic grew percent.
This report studies and analyses global Cancer Gene Testing Service status and future trends, to help determine the Cancer Gene Testing Service market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Cancer Gene Testing Service, and provides market size (US$ million) and Year-over-Year growth, considering 2022 as the base year.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
To assess the competitive environment within the market including supplier revenue, market share, and company profiles.
Highlights
(1) Global Cancer Gene Testing Service market size, history data 2018-2023, and forecast data 2024-2029, (US$ million)
(2) Global Cancer Gene Testing Service by company, revenue, market share and industry ranking 2018-2023, (US$ million)
(3) China Cancer Gene Testing Service by company, revenue, market share and industry ranking 2018-2023, (US$ million)
(4) Global Cancer Gene Testing Service key consuming regions, consumption value and demand structure
(5) Cancer Gene Testing Service industry chains, upstream, midstream and downstream
Market segment by players, this report covers
Natera, Inc.
Laboratory Corporation of America Holdings
F. Hoffmann-La Roche Ltd
Quest Diagnostics Incorporated
CooperSurgical, Inc.
Agilent Technologies, Inc.
Thermo Fisher Scientific, Inc.
Twist Bioscience
Sophia Genetics
Fulgent Genetic, Inc.
Market segment by Type, covers
Breast Cancer Risk Genetic Testing
Stomach Cancer Risk Gene Testing
Rectal Cancer Risk Genetic Testing
Others
Market segment by Application, can be divided into
Hospital
Clinic
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe Cancer Gene Testing Service product scope, global consumption value, China consumption value, development opportunities, challenges, trends, and policies.
Chapter 2: Global Cancer Gene Testing Service market share and ranking of major manufacturers, revenue, 2018-2023
Chapter 3: China Cancer Gene Testing Service market share and ranking of major manufacturers, revenue, 2018-2023
Chapter 4: Cancer Gene Testing Service industry chain, upstream, medium-stream, and downstream.
Chapter 5: Segment by Type, consumption value, percent & CAGR, 2018-2029
Chapter 6: Segment by Application, consumption value, percent & CAGR, 2018-2029
Chapter 7: Segment in regional level, consumption value, percent & CAGR, 2018-2029
Chapter 8: Segment in country level, consumption value, percent & CAGR, 2018-2029
Chapter 9: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, revenue, gross margin.
Chapter 10: Conclusions
1 Market Overview
1.1 Cancer Gene Testing Service Definition
1.2 Global Cancer Gene Testing Service Market Size and Forecast
1.3 China Cancer Gene Testing Service Market Size and Forecast
1.4 China Percentage in Global Market
1.5 Cancer Gene Testing Service Market Size: China VS Global Growth Rate, 2018-2029
1.6 Cancer Gene Testing Service Market Dynamics
1.6.1 Cancer Gene Testing Service Market Drivers
1.6.2 Cancer Gene Testing Service Market Restraints
1.6.3 Cancer Gene Testing Service Industry Trends
1.6.4 Cancer Gene Testing Service Industry Policy
2 Global Leading Players and Market Share
2.1 By Revenue of Cancer Gene Testing Service, Global Market Share by Company, 2018-2023
2.2 Global Cancer Gene Testing Service Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.3 Global Cancer Gene Testing Service Concentration Ratio
2.4 Global Cancer Gene Testing Service Mergers & Acquisitions, Expansion Plans
2.5 Global Cancer Gene Testing Service Major Companies Product Type
2.6 Head Office and Cancer Gene Testing Service Production Site of Key Manufacturer
3 China Leading Players, Market Share and Ranking
3.1 By Revenue of Cancer Gene Testing Service, China Market Share by Company, 2018-2023
3.2 China Cancer Gene Testing Service Participants, Market Position (Tier 1, Tier 2, and Tier 3)
4 Industry Chain Analysis
4.1 Cancer Gene Testing Service Industry Chain
4.2 Cancer Gene Testing Service Upstream Analysis
4.2.1 Cancer Gene Testing Service Core Raw Materials
4.2.2 Main Manufacturers of Cancer Gene Testing Service Core Raw Materials
4.3 Midstream Analysis
4.4 Downstream Analysis
4.5 Cancer Gene Testing Service Production Mode
4.6 Cancer Gene Testing Service Procurement Model
4.7 Cancer Gene Testing Service Industry Sales Model and Sales Channels
4.7.1 Cancer Gene Testing Service Sales Model
4.7.2 Cancer Gene Testing Service Typical Distributors
5 Sights by Type
5.1 Cancer Gene Testing Service Classification
5.1.1 Breast Cancer Risk Genetic Testing
5.1.2 Stomach Cancer Risk Gene Testing
5.1.3 Rectal Cancer Risk Genetic Testing
5.1.4 Others
5.2 By Type, Global Cancer Gene Testing Service Consumption Value & CAGR, 2018 VS 2022 VS 2029
5.3 By Type, Global Cancer Gene Testing Service Consumption Value, 2018-2029
6 Sights by Application
6.1 Cancer Gene Testing Service Segment by Application
6.1.1 Hospital
6.1.2 Clinic
6.2 By Application, Global Cancer Gene Testing Service Consumption Value & CAGR, 2018 VS 2022 VS 2029
6.3 By Application, Global Cancer Gene Testing Service Consumption Value, 2018-2029
7 Sales Sights by Region
7.1 By Region, Global Cancer Gene Testing Service Consumption Value, 2018 VS 2022 VS 2029
7.2 By Region, Global Cancer Gene Testing Service Consumption Value, 2018-2029
7.3 North America
7.3.1 North America Cancer Gene Testing Service & Forecasts, 2018-2029
7.3.2 By Country, North America Cancer Gene Testing Service Market Size Market Share
7.4 Europe
7.4.1 Europe Cancer Gene Testing Service Market Size & Forecasts, 2018-2029
7.4.2 By Country, Europe Cancer Gene Testing Service Market Size Market Share
7.5 Asia Pacific
7.5.1 Asia Pacific Cancer Gene Testing Service Market Size & Forecasts, 2018-2029
7.5.2 By Country/Region, Asia Pacific Cancer Gene Testing Service Market Size Market Share
7.6 South America
7.6.1 South America Cancer Gene Testing Service Market Size & Forecasts, 2018-2029
7.6.2 By Country, South America Cancer Gene Testing Service Market Size Market Share
7.7 Middle East & Africa
8 Sales Sights by Country Level
8.1 By Country, Global Cancer Gene Testing Service Market Size & CAGR, 2018 VS 2022 VS 2029
8.2 By Country, Global Cancer Gene Testing Service Consumption Value, 2018-2029
8.3 U.S.
8.3.1 U.S. Cancer Gene Testing Service Market Size, 2018-2029
8.3.2 By Type, U.S. Cancer Gene Testing Service Consumption Value Market Share, 2022 VS 2029
8.3.3 By Application, U.S. Cancer Gene Testing Service Consumption Value Market Share, 2022 VS 2029
8.4 Europe
8.4.1 Europe Cancer Gene Testing Service Market Size, 2018-2029
8.4.2 By Type, Europe Cancer Gene Testing Service Consumption Value Market Share, 2022 VS 2029
8.4.3 By Application, Europe Cancer Gene Testing Service Consumption Value Market Share, 2022 VS 2029
8.5 China
8.5.1 China Cancer Gene Testing Service Market Size, 2018-2029
8.5.2 By Type, China Cancer Gene Testing Service Consumption Value Market Share, 2022 VS 2029
8.5.3 By Application, China Cancer Gene Testing Service Consumption Value Market Share, 2022 VS 2029
8.6 Japan
8.6.1 Japan Cancer Gene Testing Service Market Size, 2018-2029
8.6.2 By Type, Japan Cancer Gene Testing Service Consumption Value Market Share, 2022 VS 2029
8.6.3 By Application, Japan Cancer Gene Testing Service Consumption Value Market Share, 2022 VS 2029
8.7 South Korea
8.7.1 South Korea Cancer Gene Testing Service Market Size, 2018-2029
8.7.2 By Type, South Korea Cancer Gene Testing Service Consumption Value Market Share, 2022 VS 2029
8.7.3 By Application, South Korea Cancer Gene Testing Service Consumption Value Market Share, 2022 VS 2029
8.8 Southeast Asia
8.8.1 Southeast Asia Cancer Gene Testing Service Market Size, 2018-2029
8.8.2 By Type, Southeast Asia Cancer Gene Testing Service Consumption Value Market Share, 2022 VS 2029
8.8.3 By Application, Southeast Asia Cancer Gene Testing Service Consumption Value Market Share, 2022 VS 2029
8.9 India
8.9.1 India Cancer Gene Testing Service Market Size, 2018-2029
8.9.2 By Type, India Cancer Gene Testing Service Consumption Value Market Share, 2022 VS 2029
8.9.3 By Application, India Cancer Gene Testing Service Consumption Value Market Share, 2022 VS 2029
8.10 Middle East & Africa
8.10.1 Middle East & Africa Cancer Gene Testing Service Market Size, 2018-2029
8.10.2 By Type, Middle East & Africa Cancer Gene Testing Service Consumption Value Market Share, 2022 VS 2029
8.10.3 By Application, Middle East & Africa Cancer Gene Testing Service Consumption Value Market Share, 2022 VS 2029
9 Company Profile
9.1 Natera, Inc.
9.1.1 Natera, Inc. Company Information, Head Office, Market Area and Industry Position
9.1.2 Natera, Inc. Company Profile and Main Business
9.1.3 Natera, Inc. Cancer Gene Testing Service Models, Specifications and Application
9.1.4 Natera, Inc. Cancer Gene Testing Service Revenue and Gross Margin, 2018-2023
9.1.5 Natera, Inc. Recent Developments
9.2 Laboratory Corporation of America Holdings
9.2.1 Laboratory Corporation of America Holdings Company Information, Head Office, Market Area and Industry Position
9.2.2 Laboratory Corporation of America Holdings Company Profile and Main Business
9.2.3 Laboratory Corporation of America Holdings Cancer Gene Testing Service Models, Specifications and Application
9.2.4 Laboratory Corporation of America Holdings Cancer Gene Testing Service Revenue and Gross Margin, 2018-2023
9.2.5 Laboratory Corporation of America Holdings Recent Developments
9.3 F. Hoffmann-La Roche Ltd
9.3.1 F. Hoffmann-La Roche Ltd Company Information, Head Office, Market Area and Industry Position
9.3.2 F. Hoffmann-La Roche Ltd Company Profile and Main Business
9.3.3 F. Hoffmann-La Roche Ltd Cancer Gene Testing Service Models, Specifications and Application
9.3.4 F. Hoffmann-La Roche Ltd Cancer Gene Testing Service Revenue and Gross Margin, 2018-2023
9.3.5 F. Hoffmann-La Roche Ltd Recent Developments
9.4 Quest Diagnostics Incorporated
9.4.1 Quest Diagnostics Incorporated Company Information, Head Office, Market Area and Industry Position
9.4.2 Quest Diagnostics Incorporated Company Profile and Main Business
9.4.3 Quest Diagnostics Incorporated Cancer Gene Testing Service Models, Specifications and Application
9.4.4 Quest Diagnostics Incorporated Cancer Gene Testing Service Revenue and Gross Margin, 2018-2023
9.4.5 Quest Diagnostics Incorporated Recent Developments
9.5 CooperSurgical, Inc.
9.5.1 CooperSurgical, Inc. Company Information, Head Office, Market Area and Industry Position
9.5.2 CooperSurgical, Inc. Company Profile and Main Business
9.5.3 CooperSurgical, Inc. Cancer Gene Testing Service Models, Specifications and Application
9.5.4 CooperSurgical, Inc. Cancer Gene Testing Service Revenue and Gross Margin, 2018-2023
9.5.5 CooperSurgical, Inc. Recent Developments
9.6 Agilent Technologies, Inc.
9.6.1 Agilent Technologies, Inc. Company Information, Head Office, Market Area and Industry Position
9.6.2 Agilent Technologies, Inc. Company Profile and Main Business
9.6.3 Agilent Technologies, Inc. Cancer Gene Testing Service Models, Specifications and Application
9.6.4 Agilent Technologies, Inc. Cancer Gene Testing Service Revenue and Gross Margin, 2018-2023
9.6.5 Agilent Technologies, Inc. Recent Developments
9.7 Thermo Fisher Scientific, Inc.
9.7.1 Thermo Fisher Scientific, Inc. Company Information, Head Office, Market Area and Industry Position
9.7.2 Thermo Fisher Scientific, Inc. Company Profile and Main Business
9.7.3 Thermo Fisher Scientific, Inc. Cancer Gene Testing Service Models, Specifications and Application
9.7.4 Thermo Fisher Scientific, Inc. Cancer Gene Testing Service Revenue and Gross Margin, 2018-2023
9.7.5 Thermo Fisher Scientific, Inc. Recent Developments
9.8 Twist Bioscience
9.8.1 Twist Bioscience Company Information, Head Office, Market Area and Industry Position
9.8.2 Twist Bioscience Company Profile and Main Business
9.8.3 Twist Bioscience Cancer Gene Testing Service Models, Specifications and Application
9.8.4 Twist Bioscience Cancer Gene Testing Service Revenue and Gross Margin, 2018-2023
9.8.5 Twist Bioscience Recent Developments
9.9 Sophia Genetics
9.9.1 Sophia Genetics Company Information, Head Office, Market Area and Industry Position
9.9.2 Sophia Genetics Company Profile and Main Business
9.9.3 Sophia Genetics Cancer Gene Testing Service Models, Specifications and Application
9.9.4 Sophia Genetics Cancer Gene Testing Service Revenue and Gross Margin, 2018-2023
9.9.5 Sophia Genetics Recent Developments
9.10 Fulgent Genetic, Inc.
9.10.1 Fulgent Genetic, Inc. Company Information, Head Office, Market Area and Industry Position
9.10.2 Fulgent Genetic, Inc. Company Profile and Main Business
9.10.3 Fulgent Genetic, Inc. Cancer Gene Testing Service Models, Specifications and Application
9.10.4 Fulgent Genetic, Inc. Cancer Gene Testing Service Revenue and Gross Margin, 2018-2023
9.10.5 Fulgent Genetic, Inc. Recent Developments
10 Conclusion
11 Appendix
11.1 Research Methodology
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Market Estimation Model
11.4 Disclaimer
Table 1. Cancer Gene Testing Service Consumption Value & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. Cancer Gene Testing Service Market Restraints
Table 3. Cancer Gene Testing Service Market Trends
Table 4. Cancer Gene Testing Service Industry Policy
Table 5. Global Cancer Gene Testing Service Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 6. Global Cancer Gene Testing Service Revenue Share by Company, 2018-2023, Ranked by Data of 2022
Table 7. Global Cancer Gene Testing Service Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 8. Global Cancer Gene Testing Service Mergers & Acquisitions, Expansion Plans
Table 9. Global Cancer Gene Testing Service Major Companies Product Type
Table 10. Head Office and Area Served of Key Players
Table 11. China Cancer Gene Testing Service Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 12. China Cancer Gene Testing Service Revenue Market Share by Company, 2018-2023
Table 13. Global Key Players of Cancer Gene Testing Service Upstream (Raw Materials)
Table 14. Global Cancer Gene Testing Service Typical Customers
Table 15. Cancer Gene Testing Service Typical Distributors
Table 16. By Type, Global Cancer Gene Testing Service Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 17. By Application, Global Cancer Gene Testing Service Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 18. By Region, Global Cancer Gene Testing Service Consumption Value, 2018 VS 2022 VS 2029, US$ Million
Table 19. By Region, Global Cancer Gene Testing Service Consumption Value, 2018-2029, US$ Million
Table 20. By Country, Global Cancer Gene Testing Service Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 21. By Country, Global Cancer Gene Testing Service Consumption Value, 2018-2029, US$ Million
Table 22. By Country, Global Cancer Gene Testing Service Consumption Value Market Share, 2018-2029
Table 23. Natera, Inc. Company Information, Head Office, Market Area and Industry Position
Table 24. Natera, Inc. Company Profile and Main Business
Table 25. Natera, Inc. Cancer Gene Testing Service Models, Specifications, and Application
Table 26. Natera, Inc. Cancer Gene Testing Service Revenue and Gross Margin, US$ Million, 2018-2023
Table 27. Natera, Inc. Recent Developments
Table 28. Laboratory Corporation of America Holdings Company Information, Head Office, Market Area and Industry Position
Table 29. Laboratory Corporation of America Holdings Company Profile and Main Business
Table 30. Laboratory Corporation of America Holdings Cancer Gene Testing Service Models, Specifications, and Application
Table 31. Laboratory Corporation of America Holdings Cancer Gene Testing Service Revenue and Gross Margin, US$ Million, 2018-2023
Table 32. Laboratory Corporation of America Holdings Recent Developments
Table 33. F. Hoffmann-La Roche Ltd Company Information, Head Office, Market Area and Industry Position
Table 34. F. Hoffmann-La Roche Ltd Company Profile and Main Business
Table 35. F. Hoffmann-La Roche Ltd Cancer Gene Testing Service Models, Specifications, and Application
Table 36. F. Hoffmann-La Roche Ltd Cancer Gene Testing Service Revenue and Gross Margin, US$ Million, 2018-2023
Table 37. F. Hoffmann-La Roche Ltd Recent Developments
Table 38. Quest Diagnostics Incorporated Company Information, Head Office, Market Area and Industry Position
Table 39. Quest Diagnostics Incorporated Company Profile and Main Business
Table 40. Quest Diagnostics Incorporated Cancer Gene Testing Service Models, Specifications, and Application
Table 41. Quest Diagnostics Incorporated Cancer Gene Testing Service Revenue and Gross Margin, US$ Million, 2018-2023
Table 42. Quest Diagnostics Incorporated Recent Developments
Table 43. CooperSurgical, Inc. Company Information, Head Office, Market Area and Industry Position
Table 44. CooperSurgical, Inc. Company Profile and Main Business
Table 45. CooperSurgical, Inc. Cancer Gene Testing Service Models, Specifications, and Application
Table 46. CooperSurgical, Inc. Cancer Gene Testing Service Revenue and Gross Margin, US$ Million, 2018-2023
Table 47. CooperSurgical, Inc. Recent Developments
Table 48. Agilent Technologies, Inc. Company Information, Head Office, Market Area and Industry Position
Table 49. Agilent Technologies, Inc. Company Profile and Main Business
Table 50. Agilent Technologies, Inc. Cancer Gene Testing Service Models, Specifications, and Application
Table 51. Agilent Technologies, Inc. Cancer Gene Testing Service Revenue and Gross Margin, US$ Million, 2018-2023
Table 52. Agilent Technologies, Inc. Recent Developments
Table 53. Thermo Fisher Scientific, Inc. Company Information, Head Office, Market Area and Industry Position
Table 54. Thermo Fisher Scientific, Inc. Company Profile and Main Business
Table 55. Thermo Fisher Scientific, Inc. Cancer Gene Testing Service Models, Specifications, and Application
Table 56. Thermo Fisher Scientific, Inc. Cancer Gene Testing Service Revenue and Gross Margin, US$ Million, 2018-2023
Table 57. Thermo Fisher Scientific, Inc. Recent Developments
Table 58. Twist Bioscience Company Information, Head Office, Market Area and Industry Position
Table 59. Twist Bioscience Company Profile and Main Business
Table 60. Twist Bioscience Cancer Gene Testing Service Models, Specifications, and Application
Table 61. Twist Bioscience Cancer Gene Testing Service Revenue and Gross Margin, US$ Million, 2018-2023
Table 62. Twist Bioscience Recent Developments
Table 63. Sophia Genetics Company Information, Head Office, Market Area and Industry Position
Table 64. Sophia Genetics Company Profile and Main Business
Table 65. Sophia Genetics Cancer Gene Testing Service Models, Specifications, and Application
Table 66. Sophia Genetics Cancer Gene Testing Service Revenue and Gross Margin, US$ Million, 2018-2023
Table 67. Sophia Genetics Recent Developments
Table 68. Fulgent Genetic, Inc. Company Information, Head Office, Market Area and Industry Position
Table 69. Fulgent Genetic, Inc. Company Profile and Main Business
Table 70. Fulgent Genetic, Inc. Cancer Gene Testing Service Models, Specifications, and Application
Table 71. Fulgent Genetic, Inc. Cancer Gene Testing Service Revenue and Gross Margin, US$ Million, 2018-2023
Table 72. Fulgent Genetic, Inc. Recent Developments
List of Figures
Figure 1. Cancer Gene Testing Service Picture
Figure 2. Global Cancer Gene Testing Service Consumption Value, (US$ million) & (2018-2029)
Figure 3. China Cancer Gene Testing Service Consumption Value, (US$ million) & (2018-2029)
Figure 4. By Consumption Value, China Cancer Gene Testing Service Market Share of Global, 2018-2029
Figure 5. Global Cancer Gene Testing Service Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2022
Figure 6. China Cancer Gene Testing Service Key Participants, Market Share, 2022
Figure 7. Cancer Gene Testing Service Industry Chain
Figure 8. Cancer Gene Testing Service Procurement Model
Figure 9. Cancer Gene Testing Service Sales Model
Figure 10. Cancer Gene Testing Service Sales Channels, Direct Sales, and Distribution
Figure 11. Breast Cancer Risk Genetic Testing
Figure 12. Stomach Cancer Risk Gene Testing
Figure 13. Rectal Cancer Risk Genetic Testing
Figure 14. Others
Figure 15. By Type, Global Cancer Gene Testing Service Consumption Value, 2018-2029, US$ Million
Figure 16. By Type, Global Cancer Gene Testing Service Consumption Value Market Share, 2018-2029
Figure 17. Hospital
Figure 18. Clinic
Figure 19. By Application, Global Cancer Gene Testing Service Consumption Value, 2018-2029, US$ Million
Figure 20. By Application, Global Cancer Gene Testing Service Consumption Value Market Share, 2018-2029
Figure 21. By Region, Global Cancer Gene Testing Service Consumption Value Market Share, 2018-2029
Figure 22. North America Cancer Gene Testing Service Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 23. By Country, North America Cancer Gene Testing Service Consumption Value Market Share, 2022
Figure 24. Europe Cancer Gene Testing Service Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 25. By Country, Europe Cancer Gene Testing Service Consumption Value Market Share, 2022
Figure 26. Asia Pacific Cancer Gene Testing Service Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 27. By Country/Region, Asia Pacific Cancer Gene Testing Service Consumption Value Market Share, 2022
Figure 28. South America Cancer Gene Testing Service Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 29. By Country, South America Cancer Gene Testing Service Consumption Value Market Share, 2022
Figure 30. Middle East & Africa Cancer Gene Testing Service Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 31. U.S. Cancer Gene Testing Service Consumption Value, 2018-2029, US$ Million
Figure 32. By Type, U.S. Cancer Gene Testing Service Consumption Value Market Share, 2022 VS 2029
Figure 33. By Application, U.S. Cancer Gene Testing Service Consumption Value Market Share, 2022 VS 2029
Figure 34. Europe Cancer Gene Testing Service Consumption Value, 2018-2029, US$ Million
Figure 35. By Type, Europe Cancer Gene Testing Service Consumption Value Market Share, 2022 VS 2029
Figure 36. By Application, Europe Cancer Gene Testing Service Consumption Value Market Share, 2022 VS 2029
Figure 37. China Cancer Gene Testing Service Consumption Value, 2018-2029, US$ Million
Figure 38. By Type, China Cancer Gene Testing Service Consumption Value Market Share, 2022 VS 2029
Figure 39. By Application, China Cancer Gene Testing Service Consumption Value Market Share, 2022 VS 2029
Figure 40. Japan Cancer Gene Testing Service Consumption Value, 2018-2029, US$ Million
Figure 41. By Type, Japan Cancer Gene Testing Service Consumption Value Market Share, 2022 VS 2029
Figure 42. By Application, Japan Cancer Gene Testing Service Consumption Value Market Share, 2022 VS 2029
Figure 43. South Korea Cancer Gene Testing Service Consumption Value, 2018-2029, US$ Million
Figure 44. By Type, South Korea Cancer Gene Testing Service Consumption Value Market Share, 2022 VS 2029
Figure 45. By Application, South Korea Cancer Gene Testing Service Consumption Value Market Share, 2022 VS 2029
Figure 46. Southeast Asia Cancer Gene Testing Service Consumption Value, 2018-2029, US$ Million
Figure 47. By Type, Southeast Asia Cancer Gene Testing Service Consumption Value Market Share, 2022 VS 2029
Figure 48. By Application, Southeast Asia Cancer Gene Testing Service Consumption Value Market Share, 2022 VS 2029
Figure 49. India Cancer Gene Testing Service Consumption Value, 2018-2029, US$ Million
Figure 50. By Type, India Cancer Gene Testing Service Consumption Value Market Share, 2022 VS 2029
Figure 51. By Application, India Cancer Gene Testing Service Consumption Value Market Share, 2022 VS 2029
Figure 52. Middle East & Africa Cancer Gene Testing Service Consumption Value, 2018-2029, US$ Million
Figure 53. By Type, Middle East & Africa Cancer Gene Testing Service Consumption Value Market Share, 2022 VS 2029
Figure 54. By Application, Middle East & Africa Cancer Gene Testing Service Consumption Value Market Share, 2022 VS 2029
Figure 55. Research Methodology
Figure 56. Breakdown of Primary Interviews
Figure 57. Bottom-up and Top-down Approaches
Figure 58. Top-down Approaches
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
Historical Data (2015-2019) |
|
|
Influencing Factors |
|
|
Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
Market Size |
|
|
Market Position of Top Company |
|
|
Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
Primary Sources | Parameters | Key Data |
Market Segments(by Application, by Type) |
|
|
Total Market |
|
|